Please login to the form below

Not currently logged in
Email:
Password:

Genocea Biosciences

This page shows the latest Genocea Biosciences news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II. Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    outbreaks. Last year, Sanofi set up an alliance with Immune Design to develop a therapeutic vaccine for HSV-2 based on their two vaccine candidates, while Genocea Biosciences, Agenus and Tomegavax

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics